Clinical Response to Futibatinib in Patients with High-Level FGFR2-Amplified Advanced Gastric Cancer: Two Case Reports-Reference-Cited by-同舟云学术

Clinical Response to Futibatinib in Patients with High-Level FGFR2-Amplified Advanced Gastric Cancer: Two Case Reports

Published:2022-07-19 Issue:8 Volume:42 Page:697-701
ISSN:1173-2563
Container-title:Clinical Drug Investigation
language:en
Short-container-title:Clin Drug Investig

Author:

Quinzii Alberto,Zecchetto Camilla,Casalino Simona,Gaule Marina,Pesoni Camilla,Merz Valeria,Contarelli Serena,Pietrobono Silvia,Benhadji Karim A.,Melisi Davide

Funder

Ministero della Salute

Associazione Italiana per la Ricerca sul Cancro

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s40261-022-01183-1.pdf

Reference17 articles.

1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.

2. Fanotto V, Uccello M, Pecora I, Rimassa L, Leone F, Rosati G, et al. Outcomes of advanced gastric cancer patients treated with at least three lines of systemic chemotherapy. Oncologist. 2017;22(12):1463–9.

3. Cancer Genome Atlas Research N. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014;513(7517):202–9.

4. Piro G, Carbone C, Santoro R, Tortora G, Melisi D. Predictive biomarkers for the treatment of resectable esophageal and esophago-gastric junction adenocarcinoma: from hypothesis generation to clinical validation. Expert Rev Mol Diagn. 2018;18(4):357–70.

5. Cavaliere A, Merz V, Casalino S, Zecchetto C, Simionato F, Salt HL, et al. Novel biomarkers for prediction of response to preoperative systemic therapies in gastric cancer. J Gastric Cancer. 2019;19(4):375–92.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A case of treatment-resistant advanced gastric cancer with FGFR2 gene alteration successfully treated with pemigatinib;International Cancer Conference Journal;2024-03-09

2. The Efficacy of Pemigatinib in Advanced NSCLC With FGFR Aberration: Case Report;Clinical Lung Cancer;2024-01

3. Targeting FGFR Pathway Is Not an Effective Therapeutic Strategy in Patients with Unselected Metastatic Esophagogastric Cancer Resistant to Trastuzumab;Journal of Personalized Medicine;2023-03-11

4. Patient Selection Approaches in FGFR Inhibitor Trials—Many Paths to the Same End?;Cells;2022-10-10

5. Tanshinone IIA May Inhibit Gastric Cancer via Affecting the Intestinal Microbiome;Computational and Mathematical Methods in Medicine;2022-09-26